Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07402330

Pharmacokinetic Study of DA-020

Status
Not Yet Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Applied Biology, Inc. · Industry
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Pharmacokinetic Study of DA-020

Detailed description

A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of DA-020

Conditions

Interventions

TypeNameDescription
DRUGDA-020 (0.1%)DA-020 (0.1%)
DRUGDA-020 (0.2%)DA-020 (0.2%)
DRUGDA-020 (0.5%)DA-020 (0.5%)

Timeline

Start date
2026-04-16
Primary completion
2026-10-19
Completion
2026-11-30
First posted
2026-02-11
Last updated
2026-04-13

Locations

2 sites across 2 countries: Brazil, Italy

Source: ClinicalTrials.gov record NCT07402330. Inclusion in this directory is not an endorsement.

Pharmacokinetic Study of DA-020 (NCT07402330) · Clinical Trials Directory